Label Changes for:

Prevacid (lansoprazole) Delayed-Release CapsulesPrevacid (lansoprazole) Delayed-Release Orally Disintegrating Tablets

May 2012

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

 

May 2012

5 WARNINGS AND PRECAUTIONS

5.4 Concomitant Use of PREVACID with Methotrexate
  • Literature suggests that concomitant use of PPIs with methotrexate .....

7 DRUG INTERACTIONS

7.6 Methotrexate
  • Case reports, published population pharmacokinetic studies, and retrospective analyses suggest that concomitant administration of PPIs and methotrexate .....

 

 

October 2011

 

DRUG INTERACTIONS

Clopidogrel
  • Concomitant administration of lansoprazole and clopidogrel in healthy subjects had no clinically important effect....

 

also see:

 

CLINICAL PHARMACOLOGY

Pharmacokinetics
  • Clopidogrel...

 

Hide
(web3)